Greenridge initiated coverage of EUDA Health (EUDA) with a Buy rating and $6 price target EUDA, a healthcare technology company based in Singapore, offers both digital healthcare management and advanced technological wellness/preventative treatments, notes the analyst, who argues that the company’s Euda Health software is “an undervalued gem” that could be quickly scaled organically or through acquisitions to attract new corporate clients in Singapore and the greater APAC region.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter